FDA Inspection 1191115 — Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc.
The FDA completed an inspection of Teva Pharmaceutical industries, Ltd. dba Watson Therapeutics, Inc. on October 31, 2022 in Miramar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 31, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miramar, FL (United States)
Additional Details
Clinical BA/BE